ID: ALA3350339

Max Phase: Preclinical

Molecular Formula: C14H24ClNO2

Molecular Weight: 237.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1cc(OC)c(C[C@@H](N)CC)cc1OC.Cl

Standard InChI:  InChI=1S/C14H23NO2.ClH/c1-5-10-8-14(17-4)11(7-12(15)6-2)9-13(10)16-3;/h8-9,12H,5-7,15H2,1-4H3;1H/t12-;/m0./s1

Standard InChI Key:  PYRHVCMHEIGOAR-YDALLXLXSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 237.34Molecular Weight (Monoisotopic): 237.1729AlogP: 2.55#Rotatable Bonds: 6
Polar Surface Area: 44.48Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.97CX LogP: 2.97CX LogD: 0.53
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.83Np Likeness Score: 0.16

References

1. Standridge RT, Howell HG, Tilson HA, Chamberlain JH, Holava HM, Gylys JA, Partyka RA, Shulgin AT..  (1980)  Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.,  23  (2): [PMID:7359529] [10.1021/jm00176a010]

Source